Avenue Therapeutics, Inc.

ATXI · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$2,594$1,783$6,708$3,763
Short-Term Investments$0$0$0$0
Receivables$0$0$0$90
Inventory$0$0$0$0
Other Curr. Assets$78$67$137$107
Total Curr. Assets$2,672$1,850$6,845$3,960
Property Plant & Equip (Net)$0$0$0$0
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$0$67$0$0
Total NC Assets$0$67$0$0
Other Assets$0-$67$0$0
Total Assets$2,672$1,850$6,845$3,960
Liabilities
Payables$155$401$150$304
Short-Term Debt$0$0$0$0
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$661$795$3,429$205
Total Curr. Liab.$816$1,196$3,579$509
LT Debt$0$0$0$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0-$0$0
Total NC Liab.$0$0-$0$0
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$816$1,196$3,579$509
Equity
Pref Stock$0$0$0$0
Common Stock$0$3$0$0
Retained Earnings-$102,580-$90,928-$80,551-$76,999
AOCI$0$0$0$0
Other Equity$105,377$92,507$84,456$80,450
Total Equity$2,797$1,582$3,905$3,451
Supplemental Information
Minority Interest-$941-$928-$639$0
Total Liab. & Tot. Equity$2,672$1,850$6,845$3,960
Net Debt-$2,594-$1,783-$6,708-$3,763